What are the symptoms and treatment of Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms and Treatment of Helicobacter pylori Infection

H. pylori infection commonly presents with dyspeptic symptoms including epigastric pain and nausea, and while many infections are asymptomatic, treatment is strongly recommended using bismuth quadruple therapy for 14 days as first-line therapy to prevent complications such as peptic ulcer disease and gastric cancer.

Common Symptoms of H. pylori Infection

H. pylori infection can present with various symptoms, though many infections remain asymptomatic:

  • Primary symptoms:

    • Dyspepsia (indigestion)
    • Epigastric pain (significantly associated with active infection) 1
    • Nausea 1
    • Weight loss (alarm symptom)
    • Anemia (alarm symptom)
  • Alarm symptoms requiring immediate specialist referral:

    • Dysphagia
    • Palpable abdominal mass
    • Malabsorption
    • Weight loss
    • Anemia 2

Diagnostic Approach

The diagnostic approach depends on patient age and presence of alarm symptoms:

  • Patients <45 years without alarm symptoms:

    • Test for H. pylori using non-invasive methods
    • Recommended tests:
      • 13C-urea breath test (UBT) - gold standard with excellent sensitivity (95%) and specificity (90%) 2, 3
      • Laboratory serology (validated locally) 2
      • Monoclonal stool antigen test (comparable accuracy to UBT) 3
  • Patients >45 years with severe symptoms OR any patient with alarm symptoms:

    • Immediate referral to specialist for endoscopy 2
    • Biopsy for histology, culture, and rapid urease test 4

Treatment Recommendations

First-Line Treatment

For treatment-naïve patients:

  • Bismuth quadruple therapy (preferred regimen when antibiotic susceptibility is unknown) 3, 5:

    • PPI (high-dose) twice daily
    • Bismuth subcitrate ~300mg four times daily
    • Metronidazole 500mg three times daily
    • Tetracycline 500mg four times daily
    • Duration: 14 days (85% eradication rate) 3
  • Alternative regimens:

    • Triple therapy with clarithromycin and lansoprazole 6:
      • Amoxicillin 1g twice daily
      • Clarithromycin 500mg twice daily
      • PPI (lansoprazole) twice daily
      • Duration: 14 days

Treatment for Refractory Infection

For patients who fail initial treatment:

  • If bismuth quadruple therapy failed:

    • Levofloxacin-based triple therapy OR
    • Rifabutin-based triple therapy 3
  • If clarithromycin-based triple therapy failed:

    • Bismuth quadruple therapy 3

Optimizing Treatment Success

  • Maximize acid suppression:

    • Use high-dose PPIs (increases eradication rates by 6-10%)
    • Administer PPI 30 minutes before meals on empty stomach 3
  • Optimize antibiotic dosing:

    • Amoxicillin: at least 2g daily in 3-4 divided doses
    • Metronidazole: 1.5-2g daily in divided doses 3
  • Treatment duration:

    • 14-day regimens are strongly recommended over 7-day regimens (approximately 5% better eradication rates) 3

Post-Treatment Follow-up

  • Confirm eradication at least 4 weeks after completing treatment 3
  • Use urea breath test or monoclonal stool antigen test
  • Ensure patient has been off PPI for at least 2 weeks before testing 3

Common Pitfalls to Avoid

  • Reusing failed antibiotics, particularly clarithromycin and levofloxacin 3
  • Inadequate PPI dosing, which significantly reduces eradication rates 3
  • Short treatment duration (7-day regimens have lower success rates) 3
  • Ignoring prior antibiotic exposure 3
  • Failing to refer patients with alarm symptoms for endoscopy 2

Special Considerations

  • Penicillin allergy: Use bismuth-based quadruple therapy with tetracycline and metronidazole 3
  • Renal impairment: Adjust amoxicillin dosing based on GFR 3
  • Bleeding ulcers: Start treatment when oral feeding is resumed 3

H. pylori eradication has been shown to prevent relapse of duodenal ulcers and reduce the risk of gastric cancer, making proper diagnosis and treatment essential for improving long-term outcomes 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Refractory H. pylori Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.